Top StoriesTechFinanceHealthEnergySportsCulture
Tech & Science

It’s not easy to get depression-detecting AI through the FDA

By The Verge AI · 2026-04-03
It’s not easy to get depression-detecting AI through the FDA
Why it matters: Kintsugi's shutdown highlights the significant regulatory hurdles for novel AI in healthcare, impacting future mental health screening innovations.
Kintsugi, a California startup, is shutting down and open-sourcing most of its AI technology designed to detect depression and anxiety from speech after failing to secure timely FDA clearance. The company's innovative approach, which analyzed how people speak rather than what they say, aimed to complement or replace traditional self-report screening tools but faced significant hurdles navigating the FDA's regulatory framework, which is ill-suited for rapidly evolving AI. While Kintsugi's core healthcare mission ends, elements of its technology may find new life in other sectors, including deepfake detection.

Share this story

More tech & science → Read original →

Get tech & science in your inbox

The best stories, summarized daily. Free.

No spam. Unsubscribe anytime.